Revamilast (GRC 4039) is an orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 of 3 nM. Revamilast inhibits the production of TNF-alpha. It can be used for research on rheumatoid arthritis, plaque psoriasis, asthma, and other inflammatory diseases[1].
Molecular Weight:
440.18
CAS Number:
[893555-90-3]
Formula:
C18H9Cl2F2N3O4
Target:
Phosphodiesterase (PDE),TNF Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
